Exosomal lncRNA Nuclear Paraspeckle Assembly Transcript 1 (NEAT1)contributes to the progression of allergic rhinitis via modulating microRNA-511/Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2) axis.
Allergic rhinitis
NEAT1
NR4A2
interleukin-13
miR-511
Journal
Bioengineered
ISSN: 2165-5987
Titre abrégé: Bioengineered
Pays: United States
ID NLM: 101581063
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
21
10
2021
pubmed:
22
10
2021
medline:
16
2
2022
Statut:
ppublish
Résumé
Allergic rhinitis (AR) is a common chronic disease characterized by inflammation of the nasal mucosa. Long non-coding RNA (LncRNA) has been reported to be involved in the pathogenesis of various diseases. However, the biological roles of lncRNA Nuclear Paraspeckle Assembly Transcript 1 (NEAT1) in AR are still unclear. The mRNA levels of NEAT1, miR-511, and Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2) were detected by RT-qPCR. The protein levels of exosomal markers were examined by western blot. ELISA was used to assess the levels of GM-CSF, eotaxin-1, and MUC5AC. The cell viability and apoptosis were evaluated by CCK-8 and TUNEL assays. In this study, we found that the NEAT1 level was highly expressed in AR and IL-13-treated HNECs. NEAT1 interference significantly suppressed levels of GM-CSF, eotaxin-1, and MUC5AC and apoptosis rate, but promoted the viability of IL-13-treated human nasal epithelial cells (HNECs). Moreover, exosomes containing NEAT1 induced inflammatory cytokine production and apoptosis, while NEAT1 depletion abrogated these effects. In addition, NEAT1 directly interacted with miR-511, and the inhibition of miR-511 partially restored the inhibitory effects of NEAT1 silencing on inflammatory cytokine, mucus production, and apoptosis in IL-13-stimulated HNECs. Furthermore, miR-511 could bind to the 3'UTR of NR4A2, and the inhibition of miR-511 increased levels of inflammatory factors and apoptosis rate, which was counteracted by depleting NR4A2. In conclusion, our data revealed that exosomal NEAT1 contributed to the pathogenesis of AR through the miR-511/NR4A2 axis. These findings might offer novel strategies for the prevention and treatment of AR.
Identifiants
pubmed: 34672863
doi: 10.1080/21655979.2021.1982313
pmc: PMC8806616
doi:
Substances chimiques
Cytokines
0
Interleukin-13
0
MIRN511 microRNA, human
0
MicroRNAs
0
NEAT1 long non-coding RNA, human
0
NR4A2 protein, human
0
Nuclear Receptor Subfamily 4, Group A, Member 2
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8067-8079Références
Pharmacol Ther. 2017 Jun;174:63-78
pubmed: 28202367
Bioengineered. 2021 Dec;12(1):96-107
pubmed: 33345740
Mol Med Rep. 2020 Dec;22(6):5313-5325
pubmed: 33174011
Mediators Inflamm. 2020 Jan 17;2020:9743037
pubmed: 32410875
Bioengineered. 2021 Dec;12(1):162-171
pubmed: 33356805
J Cell Physiol. 2019 Apr;234(4):5319-5326
pubmed: 30259979
Int Immunopharmacol. 2019 Oct;75:105731
pubmed: 31344555
Proteomics. 2016 Apr;16(7):1131-45
pubmed: 26806198
J Mol Endocrinol. 2018 Oct 15;61(4):231-239
pubmed: 30328354
PLoS One. 2013;8(2):e56595
pubmed: 23437182
Aging (Albany NY). 2019 Jun 13;11(11):3716-3730
pubmed: 31195367
Bioengineered. 2021 Dec;12(1):44-53
pubmed: 33345684
Mediators Inflamm. 2020 Feb 5;2020:8019467
pubmed: 32089649
Front Cell Dev Biol. 2020 Sep 11;8:551681
pubmed: 33042992
Neoplasia. 2021 Jul;23(7):692-703
pubmed: 34153644
Ther Adv Chronic Dis. 2021 Apr 27;12:2040622321991705
pubmed: 33995991
Circ Res. 2011 Feb 4;108(3):335-43
pubmed: 21164106
Mol Immunol. 2020 Feb;118:30-39
pubmed: 31841965
Curr Allergy Asthma Rep. 2016 Sep;16(9):67
pubmed: 27585977
Mol Immunol. 2009 Oct;46(16):3345-57
pubmed: 19732956
Am J Transl Res. 2019 Sep 15;11(9):5944-5955
pubmed: 31632562
Cancer Cell Int. 2018 Jan 23;18:11
pubmed: 29410604
Medicine (Baltimore). 2019 May;98(20):e15247
pubmed: 31096432
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Nat Med. 2002 Aug;8(8):885-9
pubmed: 12091879
Curr Opin Allergy Clin Immunol. 2008 Feb;8(1):1-9
pubmed: 18188010
Eur J Pharmacol. 2020 Apr 5;872:172977
pubmed: 32007500
Biochem Biophys Res Commun. 2015 Jan 30;457(1):58-64
pubmed: 25529447
J Innate Immun. 2020;12(1):116-128
pubmed: 31315126
IUBMB Life. 2020 Nov;72(11):2499-2507
pubmed: 32916037
J Nanobiotechnology. 2020 Oct 31;18(1):157
pubmed: 33129330
Arch Biochem Biophys. 2019 Mar 15;663:183-191
pubmed: 30639170
Ann Clin Transl Neurol. 2015 Apr;2(4):353-61
pubmed: 25909081
Cell Death Discov. 2018 Feb 15;4:27
pubmed: 29531824
Medicine (Baltimore). 2021 Jan 29;100(4):e22946
pubmed: 33530155
Onco Targets Ther. 2018 Nov 27;11:8399-8408
pubmed: 30568463
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8076-8083
pubmed: 30556842
Nat Commun. 2019 Apr 2;10(1):1495
pubmed: 30940803